Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways

Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
32 participants needed
1 Location

Brief description of study

DPP4 is an enzyme that breaks down proteins that may affect blood sugar and the heart. We will recruit individuals from the Penn Biobank (cases, controls). Participants will be asked to complete a meal test, DXA, and echocardiogram with exercise. A cardiac MRI and related pilot study are optional.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: heart,cardio,cardiology
  • Age: 18 years - 99 years
  • Gender: All


Updated on 02 Jul 2025. Study ID: 19-1197
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research